UBS Group
DXTR

UBS Group’s Dextera Surgical Inc. DXTR Stock Holding History

UBS Group’s Portfolio DXTR Stock Details DXTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-48,825
Closed -$14K – 8375
2017
Q3 		$14K Buy
48,825
+38,618
+378% +$11.1K ﹤0.01% 6721
2017
Q2 		$3K Sell
10,207
-1,824
-15% -$923 ﹤0.01% 7341
2017
Q1 		$13K Buy
12,031
+6,049
+101% +$7.77K ﹤0.01% 6483
2016
Q4 		$6K Buy
5,982
+2,972
+99% +$4.47K ﹤0.01% 7193
2016
Q3 		$6K Sell
3,010
-2,307
-43% -$4.91K ﹤0.01% 7097
2016
Q2 		$10K Buy
+5,317
New +$10.9K ﹤0.01% 6813

Other funds holding DXTR

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

UBS Group's DXTR Position: Q4 2017 in Review

UBS Group sold out of Dextera Surgical Inc. (DXTR) in Q4 2017, closing a stake of 48,825 shares — an estimated $14K sold.

UBS Group first reported a position in DXTR in Q2 2016 and held it in 6 quarters. The position peaked at $14K in Q3 2017. 3 funds tracked by Wall St. Rank hold DXTR as of Q4 2017.

  • UBS Group reported no remaining Dextera Surgical Inc. position as of Q4 2017 after selling out during the quarter.
  • UBS Group sold 48,825 Dextera Surgical Inc. shares in Q4 2017, an estimated $14K.
  • UBS Group first reported a position in Dextera Surgical Inc. in Q2 2016 and held it in 6 quarters.
  • UBS Group's Dextera Surgical Inc. position peaked at $14K in Q3 2017.
  • 3 funds tracked by Wall St. Rank held Dextera Surgical Inc. as of Q4 2017.

Based on UBS Group's 13F filing for Q4 2017, filed 14 Feb 2018.